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The gastrointestinal microbiome is a complex ecosystem with functions that shape human health. Studying the
relationship between taxonomic alterations and functional repercussions linked to disease remains challenging. Here, we
present an integrative approach to resolve the taxonomic and functional attributes of gastrointestinal microbiota at the
metagenomic, metatranscriptomic and metaproteomic levels. We apply our methods to samples from four families with
multiple cases of type 1 diabetes mellitus (T1DM). Analysis of intra- and inter-individual variation demonstrates that
family membership has a pronounced effect on the structural and functional composition of the gastrointestinal
microbiome. In the context of T1DM, consistent taxonomic differences were absent across families, but certain human
exocrine pancreatic proteins were found at lower levels. The associated microbial functional signatures were linked to
metabolic traits in distinct taxa. The methodologies and results provide a foundation for future large-scale integrated
multi-omic analyses of the gastrointestinal microbiome in the context of host–microbe interactions in human health
and disease.
Metagenomic studies of faecal samples have provided deepinsights into the structure and functional potential ofmicrobial communities within the human gastrointestinal
tract1,2, revealing their inter-individual variability3 and apparent
intra-individual stability4,5. Case–control studies have associated
microbial traits in individuals with patterns of diseases, thereby
implicating gastrointestinal microbial communities in a range
of human disorders6–10. Metagenomics is able to resolve
differences in the functional potential of microbial communities
and has revealed a surprisingly stable set of core functions,
even though gastrointestinal community structures display
great inter-individual variation2.
These deep insights notwithstanding, metagenomics offers little
information on which microbial traits are actually contributed to
human physiology. More speciﬁcally, previous studies analysing
functional ‘omes’, such as the metatranscriptomes or the metapro-
teomes, in gastrointestinal samples9,11–17 have found that functional
genes predicted from metagenomes are not necessarily
expressed9,11–13. Furthermore, as the functional omes display
higher variability and sensitivity to perturbation9,11–13, these vari-
ations may better reﬂect disease-related changes in host–micro-
biome interactions14,15. For this reason, the integration of
metagenomic, metatranscriptomic and metaproteomic data is
expected to yield important insights into the human microbiome18,
as it has for environmental microbial consortia19,20.
Families play an important role in the formation of the micro-
biota of individuals3,21,22. More speciﬁcally, greater similarities
have been observed between the microbiota of family members
and cohabiting partners than between unrelated individuals23.
Furthermore, the microbiota of siblings have been found to be
closer to each other than to their parents’22. In the present study,
healthy family members were used as a stringent control group in
type 1 diabetes mellitus (T1DM), a disease supposedly inﬂuenced
by an interplay of genetics and environment.
The worldwide increase in the incidence of T1DM (ref. 24),
especially in individuals with a low genetic risk25, suggests that
environmental factors may trigger the autoimmune destruction
of insulin-producing beta cells in the endocrine pancreas that
causes T1DM. Gastrointestinal agents have been implicated in
this process due to the immune-modulatory role of the gastrointes-
tinal tract26,27 and the potential involvement of the pancreatic ducts
in the inﬂammation that culminates in beta-cell destruction28.
Case–control studies of the microbial community structure
during29–32, immediately after33,34 and before31,35 seroconversion,
have tried but failed to identify generalizable disease-causing or
biomarker organism signatures. The present study does not focus
on the aetiology, but examines a relatively small cohort of individ-
uals living with T1DM to determine whether there are effects
that are apparent in the structure and function of the
gastrointestinal microbiome linked to T1DM.
In this Article, we expand our recently developed methodologies
for integrated multi-omic analyses of microbial consortia36,37 to
systematically explore the variability of the different omes and
their relationships in the context of a case study of familial
T1DM. Our study allowed us to link the expression of disease-
associated microbial functions to distinct taxa, which demonstrates
the necessity for integrated multi-omic analyses of microbiota in the
context of human disease research.
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Study cohort and microbial community structures
The study cohort consisted of 20 individuals from four families of at
least two generations presenting at least two cases of T1DM (Fig. 1a).
T1DM was in all cases diagnosed for more than ﬁve years and
successfully controlled by insulin replacement therapy, and the
auto-antibody status of the healthy individuals did not indicate
immediate risk of developing T1DM (for detailed descriptions see
Supplementary Section 1 and Supplementary Table 1).
To obtain overviews of the microbial community structures in 53
well-preserved faecal samples collected over a period of two to four
months, we calculated relative abundances of metagenomic operational
taxonomic units (mOTUs)38 from 3.9 ± 0.1 Gbp (mean ± standard
deviation (s.d.)) of metagenomic data per sample (Supplementary
Section 2, Supplementary Fig. 1 and Supplementary Table 2). In
most cases, mOTU-based taxonomic proﬁles were stable over time
within individuals. Given that family members share environment,
nutrition and genetic background, families formed more distinct
groups than unrelated individuals, and samples did not cluster accord-
ing to T1DM status (Supplementary Fig. 2). Similar to earlier ana-
lyses38, 43 ± 14% of the detected microorganisms in each sample
belonged to mOTUs without a sequenced isolate genome. The relative
abundance of single mOTUs not assigned to any phylum reached up to
9% (Supplementary Section 2). These results indicate that analytical
approaches purely based on isolate reference genomes would not be
able to capture the taxonomic and functional diversity in these
microbial communities.
Integrated multi-omics
Given the considerable proportion of taxa not represented by
sequenced isolate genomes in the mOTU analyses, we devised a refer-
ence genome-independent workﬂow for the integration of metage-
nomic, metatranscriptomic and metaproteomic data (Fig. 1b). A
total of 8.0 ± 1.0 Gbp (mean ± s.d.) of metatranscriptomic sequen-
cing data and 185,000 ± 13,000 peptide mass spectra were obtained
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Figure 1 | Overview of the cohort and framework for integrated analyses. a, Pedigrees of participant families. Individuals who donated samples are
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in addition to metagenomic data from biomolecular fractions of 36
of the faecal samples collected from 18 of the individuals
(Supplementary Table 3). We approached the multi-omic data inte-
gration using a de novo genomic assembly strategy, which allowed us
to identify differences in encoded and expressed microbial functions
in the context of intra-individual variation, family membership and
T1DM. Our workﬂow, which involves the co-assembly of metage-
nomic and metatranscriptomic reads, resulted in longer total
assembled genomic contigs (287 ± 43 Mbp), longer maximal contig
lengths (310 ± 170 kbp; N50 (the largest contig length such that
50% of all assembled nucleotides are contained in contigs of at
least this size): 660 ± 130 bp) and enhanced read usage (88 ± 4%
and 88 ± 2% of the metagenomic and metatranscriptomic reads
mapping back to the assembly, respectively) when compared to
assemblies based on single omes (Supplementary Section 3,
Supplementary Fig. 3 and Supplementary Table 3). Annotations
with functional categories (KEGG orthologous groups, MetaCyc
and Swiss-Prot enzymes, Pfam or TIGR-Pfam domains) were
obtained for 489,000 ± 75,000 predicted open reading frames
(ORFs; representing 82 and 66% of the metagenomic and metatran-
scriptomic reads, respectively; Supplementary Section 3,
Supplementary Figs 4 and 5 and Supplementary Table 3).
For protein identiﬁcation from the metaproteomic data, we
assembled sample-speciﬁc search databases using the microbial
ORFs of the co-assemblies, including strain-resolved variants.
Given that a signiﬁcant proportion of human proteins are typically
present in faecal metaproteomes and that these may reﬂect host–
microbiome interactions11, we also sequenced the whole genomes
of study participants (Supplementary Table 3) and added allele-
speciﬁc individualized human protein sequences to the proteomic
search databases. This allowed us to identify 2,400 ± 1,600 microbial
and 200 ± 70 human protein groups per sample (920 ± 570 microbial
and 90 ± 30 human proteins uniquely identiﬁed; Supplementary
Section 4 and Supplementary Table 3).
Genomic context and taxonomy of expressed genes
Bacteria accounted for the majority of metagenomic, metatranscrip-
tomic and metaproteomic information (Supplementary Fig. 6). To
link the bacterial and archaeal genes to their genomic context and
thereby allow for the integration of functional data from multiple
omic levels (Fig. 1b), assembled contigs were binned using an algor-
ithm that makes use of multiple features, including genomic signa-
tures, metagenomic coverage information and the presence
of single-copy essential genes (Supplementary Section 5 and
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Figure 2 | Automated binning of contigs and population-level genome characteristics. a, Example (sample M01.2-V1) of a two-dimensional visualization of
pentamer frequency-based signatures of assembled contigs; distinct bins are highlighted based on completeness (only bins with at least 29% of essential
genes with fewer than 20% multiple copies are labelled). b, Metagenomic coverage of genes in the cluster encircled in a, which was subdivided in the
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key for subpanels a and d, with a histogram (black lines) of completeness of all binned population-level genomes with at least one essential gene.
d, Metagenomic mOTU abundances calculated from mapping reads against a collection of phylogenetic marker genes compared to a calculation based on
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e, Example of genes of a common functional category (here K03149, thiazole synthase) linked to population-level genomes with taxonomic annotations. The
taxonomic annotation of the population-level genomes recruiting >10% of the overall metagenomic reads mapping to genes with the function of interest are
indicated; all other genes are gathered in ‘others/unknown’. Groups of two or three bars represent one sample (sample names are indicated in the colour
scheme deﬁned in Fig. 1a; visit (V)1, ﬁrst sample; V2, second sample; V3, third sample), with the ﬁrst bar representing the origins of the metagenomic reads,
the middle bar representing the origins of the metatranscriptomic reads, and the (optional) last bar representing the origins of the uniquely
identiﬁed proteins.
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Supplementary Table 4). Contig bins (Fig. 2a–c), which represent
(partial) population-level genomes, were analysed in terms of
their functional annotations as well as protein-coding phylogenetic
markers. Taxonomic proﬁles from the binning were consistent with
the assembly-independent mOTU-based analysis results (Fig. 2d,
Supplementary Figs 2 and 7 and Supplementary Section 6).
Furthermore, we were able to use the information from the binned
genomic reconstructions to trace speciﬁc functions of interest to
different taxa encoding or expressing them (Fig. 2e, Supplementary
Fig. 8 and Supplementary Section 7).
In addition, non-human eukaryotic genes, transcripts and pro-
teins were detected that originated from food-borne organisms
(plants and fungi) and their viruses, as well as active gastrointestinal
eukaryotes (fungi and protists; non-human eukaryotic genes
accounted for 0.07 ± 0.05% of the metagenomic reads, 0.8 ± 1% of
the metatranscriptomic reads and 2.6 ± 3.1% of the identiﬁed
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proteins, Supplementary Section 8). Viral biomolecules represented
less than 0.1% in terms of predicted ORFs as well as mappable reads
and identiﬁed proteins (Supplementary Section 9).
Metagenomic data and functional omic data
To assess how metagenomic taxonomic proﬁles might be reﬂected
at the metatranscriptomic level, mOTU abundance proﬁles were
calculated using the metatranscriptomic reads as input, in addition
to the previous metagenome-based analyses. A similar set of
mOTUs was detected on the metagenomic and metatranscriptomic
levels (Fig. 3a), and their abundance proﬁles correlated strongly
(Spearman’s ρ = 0.81 ± 0.15; P < 2.2 × 10−16; Fig. 3b and
Supplementary Section 10). When comparing the relative mOTU
abundances at the metagenomic and metatranscriptomic levels,
apparent differences in the inferred activities of different mOTUs
in the collected faecal samples were related to their prevalence
and activity at distinct sites within the gastrointestinal tract9,
where the most transcriptionally active organisms are known resi-
dents of the lower gastrointestinal tract, and organisms with low
activity are associated with the oral cavity and upper respiratory
tract (Fig. 3b and Supplementary Section 10).
Overall, although a strong correlation was observed between meta-
genomic and metatranscriptomic reads mapping to the phylogenetic
marker genes (which are expected to be constitutively expressed), a
wide range of expression levels was observed for the other ORFs
encoded by the reconstructed genomes (Supplementary Fig. 9).
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inferred metagenomic and metatranscriptomic abundances of mOTUs, metagenomic, metatranscriptomic and metaproteomic abundances of functional
categories and human protein abundances. The colour/symbol scheme denoting the individuals is identical to that used in the other ﬁgures as deﬁned in
Fig. 1a. c, Comparison of the dissimilarities of functional potential of closely related population-level genomes reconstructed from different samples of the
same individual and genomes of related organisms reconstructed from samples of different individuals. Over the whole set of taxa, intra- and inter-individual
dissimilarity indices were signiﬁcantly different (P < 0.05, Wilcoxon signed rank test). d, Comparison of correlations between expression proﬁles of closely
related population-level genomes reconstructed from different samples of the same individual and expression proﬁles of genomes of the same organisms
reconstructed from samples of different individuals. Spearman’s correlation coefﬁcients of the functional annotations present in all analysed genomes are
displayed. Over the whole set of taxa, intra- and inter-individual correlations were signiﬁcantly different (P < 0.05, Wilcoxon signed rank test). In c and d,
only genomes with >67% essential unique genes were evaluated. The mOTUs with reconstructed genomes allowing intra- versus inter-individual comparison
of at least three individuals are displayed; upper Clostridiales mOTU: mOTU linkage group 126, Bacteroidales: mOTU linkage group 135, lower Clostridiales
mOTU: mOTU linkage group 310. Numbers of compared genomes (n) are shown as pink and blue numbers. In a, c and d, asterisks indicate statistically
signiﬁcant direct comparisons (P < 0.05, Wilcoxon rank sum test). Boxes span the ﬁrst to third quartiles, the central thick bars represent the medians,
whiskers extend to 1.5 times the interquartile ranges, and data points outside these ranges are indicated as outlier points.
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This explains the overall weak correlation between metagenomic and
metatranscriptomic depths of coverage at the level of all ORFs
(Spearman’s ρ = 0.06 ± 0.09, Fig. 3c). Within the metaproteome,
only a limited proportion of the predicted ORFs were detectable
(Fig. 3c,d and Supplementary Table 3). However, ORFs encoding
identiﬁed proteins typically exhibited higher metatranscriptomic
coverage (Kruskal–Wallis test P < 2.2 × 10−16, Fig. 3e). Stronger
variations in the metatranscriptomic levels of non-housekeeping
functions were observed, most probably due to these being differen-
tially regulated or expressed by different taxa (Supplementary Fig. 9).
This may also explain why, despite a similar overlap of detected func-
tional categories (Fig. 3f), community-wide metagenomic and meta-
transcriptomic functional proﬁles were less correlated (Spearman’s
ρ = 0.41 ± 0.08; P < 2.2 × 10−16; Fig. 3g) than the mOTU abundance
proﬁles (Supplementary Section 11). Metagenomic and metaproteo-
mic functional proﬁles did not concur (gene-wise ρ = 0.14 ± 0.08;
functional category-wise ρ = 0.10 ± 0.05; P < 0.07, Fig. 3h), but
protein abundances tended to correlate with transcript abundances
(gene-wise ρ = 0.33 ± 0.12, Supplementary Fig. 9; functional category-
wise ρ = 0.40 ± 0.16, P < 2.2× 10−16, Fig. 3i), indicating a stronger
dependence of protein expression on corresponding transcript levels.
Individuality of gut microbiota on all omic levels
The microbial consortia of the gut are known to be among the most
stable human-associated microbial communities2, and sample
donors remain identiﬁable from these based on metagenomic data
when compared to data sets from earlier samples39. We investigated
whether the patterns of individuality are also discernible on the
other omic levels. At the metagenomic level, the observed community
structures were stable over time in most individuals (Fig. 4a). More
speciﬁcally, the intra-individual distances between metagenomic
mOTU abundance proﬁles were signiﬁcantly smaller than the corre-
sponding inter-individual distances, and donors thus remained recog-
nizable based on mOTU abundance proﬁles (Supplementary Section
12 and Supplementary Fig. 10). Furthermore, signiﬁcantly greater
intra-individual than inter-individual similarities were observed in
the metatranscriptome-based taxonomic proﬁles, in the functional
proﬁles on all omic levels including the metagenome, and even in
the human protein proﬁles (Wilcoxon rank sum tests between
Jensen–Shannon or Soerensen distances: P < 0.05, Fig. 4a). Intra-
individual variability was greater in the metatranscriptome and meta-
proteome, thereby hampering recognition of samples from the same
donor (Supplementary Section 12). Taken together, these results indi-
cate that the stability of the community structurewithin the same indi-
vidual2 is reﬂected at the functional levels, which nonetheless display a
higher level of plasticity. Consequently, if the gastrointestinal micro-
biome exhibits changes in individuals with T1DM, signatures may
be reﬂected across the different omes.
Family resemblances are apparent at all omic levels
To place the observed individual microbiome signatures into
family contexts, we compared intra- and inter-family distances of
community-level taxonomic and functional proﬁles. Smaller intra-
than inter-family distances were observed between community
structures (Fig. 4a). To assess whether the observed family-speciﬁc
traits were also conserved on the other omic levels, multiple
co-inertia analysis was performed for taxonomic proﬁles based on
the metagenomic and metatranscriptomic data, for functional
proﬁles on all omic levels, as well as for the human proteome. A
remarkable level of similarity among all six levels was observed,
with particularly tight clusters observable in several families (in par-
ticular in family M04; Fig. 4b). Accordingly, intra-family distances
in terms of taxonomic and functional proﬁles were also smaller
than inter-family distances (Fig. 4a, Supplementary Section 13
and Supplementary Fig. 11).
Functional individuality of discrete genomes
In addition to community stability, the persistence of individual-
speciﬁc strains has been documented4,5. To explore whether strain
speciﬁcity also translates to the functional level, we analysed the
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Figure 5 | Abundances of exocrine pancreatic proteins in the faecal samples of individuals with T1DM and correlating transcripts for metabolic enzymes.
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encoded functional potential and corresponding expression proﬁles
of closely related reconstructed genomes recovered from different
samples. Our results revealed that the functional potentials of
related genomes reconstructed from samples of the same donor
were signiﬁcantly more similar than samples from different
donors (Wilcoxon signed rank test between Soerensen dissimilarity
indices of all tested taxa: P < 0.05, Fig. 4c, Supplementary Section 14
and Supplementary Fig. 10). Furthermore, the expression proﬁles
of these genomes displayed stronger intra-individual than inter-
individual correlations (Wilcoxon signed rank test between
Spearman’s correlation coefﬁcients of all tested taxa: P < 0.05,
Fig. 4d, Supplementary Section 14 and Supplementary Fig. 10).
Individuality is therefore a characteristic of gastrointestinal whole
microbial communities on all functional levels, and is also apparent
in the functional potential and expression proﬁles of speciﬁc
populations common to different individuals.
Family-independent effects of T1DM
As discussed above, on the level of the observed community structures
as well as the metatranscriptomic and metaproteomic functional pro-
ﬁles, large differences between families were identiﬁed. Additionally,
nutritional records of the days prior to faecal sampling revealed that
the diets of family members were very similar. In line with medical
recommendations, the individuals with T1DM followed the same
diets as their healthy family members, and their diet was no more
or less variable or rich (Supplementary Sections 1 and 15,
Supplementary Table 1, Supplementary Figs 12 and 13). Familymem-
bership thus appears to stratify the cohortmore strongly than all other
factors known to inﬂuence gastrointestinal microbial community
composition, such as age or body mass index (Supplementary
Table 1 and Supplementary Fig. 14). Consequently, we analysed
T1DM-speciﬁc differences in the microbial taxonomic and functional
proﬁles while accounting for family membership.
No differences in taxonomic or functional diversity and richness
were observed between individuals with T1DM and their healthy
relatives at any omic level (Supplementary Fig. 15). However, we
found one highly active mOTU, classiﬁed to the order
Clostridiales, to be more abundant in the metatranscriptomes of
the individuals with T1DM (main effect with false-discovery-rate
(FDR)-adjusted P < 0.05 and absolute fold change >2; Supplementary
Section 16 and Supplementary Fig. 15).
Differential transcript abundances of diverse functions
(Supplementary Fig. 16) suggested differences in the availability
or microbial use of cellulose and subtle differences in the immune
status (genes for reactive oxygen species (ROS) detoxiﬁcation, cell
surface proteins and complement-inactivating staphopain A) of
individuals with T1DM (Supplementary Section 17). The latter
group of functions was also reﬂected in the proteins, which exhib-
ited the greatest differences in terms of their abundance (not sig-
niﬁcant after FDR adjustment; Supplementary Fig. 16 and
Supplementary Section 17). T1DM-speciﬁc functions could
mostly be traced to genomes of taxa whose abundances were not
affected by T1DM (Supplementary Figs 18 and 19), which indicates
that expression of potentially disease-related community functions
may be independent of the abundances of distinct taxa inferred
from the metagenomic data alone (Supplementary Section 17).
Human protein excretion in T1DM and microbial functions
Little is known about changes in the function of the gastrointestinal
tract with respect to T1DM traits, such as the proposed heightened
innate inﬂammatory state27. Among the ten human proteins with
the greatest changes in abundance in the faeces of individuals
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Figure 6 | Multi-omic characteristics of the gastrointestinal microbiome in individuals with T1DM compared to healthy relatives. *The mentioned
Clostridiales mOTUs are not identical.
NATURE MICROBIOLOGY DOI: 10.1038/NMICROBIOL.2016.180 ARTICLES
NATURE MICROBIOLOGY | www.nature.com/naturemicrobiology 7
© 2016 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
with T1DM (Supplementary Table 5), we identiﬁed two with higher
abundance in the individuals with T1DM, namely lactotransferrin
(LTF) and the lactotransferrin receptor intelectin (ITLN1), which
maintain an important functional position at the crossroads of
iron uptake, innate immunity and insulin function40–43, and whose
antimicrobial activity may inﬂuence the gastrointestinal microbiota44
(Supplementary Section 18 and Supplementary Fig. 17).
Furthermore, we found four proteins that are preferentially
expressed in the exocrine pancreas45, α-amylase proteins AMY2A
and AMY2B (Fig. 5a,b), carboxypeptidase CPA1 and the less charac-
terized CUZD1 (Supplementary Fig 18), to be less abundant in the
stool of individuals with T1DM, potentially reﬂecting a weakening
of exocrine function. To what extent T1DM affects the exocrine pan-
creas is still a matter of debate46, and our results suggest that this may
be the case at least for certain digestive enzymes (Supplementary
Section 15). We analysed whether potential repercussions of the
apparent T1DM-related decrease in digestive enzymes (which
would probably affect starch availability in the lower intestine47)
were reﬂected in the collected samples. Because we were unable to
identify taxa whose abundances correlated with the measured abun-
dances of the pancreatic enzymes, we focused on the microbial genes
with known metabolic functions (Supplementary Section 18). We
uncovered several signiﬁcant correlations between microbial tran-
script levels and the relative abundances of the amylases AMY2A
and AMY2B (24 with P < 0.05 after FDR adjustment;
|Spearman’s ρ| > 0.75; Supplementary Table 5), including functions
related to microbial central carbon metabolism and related cofactors
(Fig. 5c), in particular thiamine biosynthesis (Supplementary
Section 18 and Supplementary Fig. 20). These functions were tran-
scribed by distinct taxa in the different samples (for example, thiazole
synthase, Fig. 2e). Low thiamine blood levels have been linked to
complications of T1DM48 and colonic uptake transporters of
thiamine have been described49. However, the observed patterns in
transcript abundances of thiazole synthase and plasma thiamine
levels were not correlated in the small subset of individuals who
did not take thiamine supplements, precluding any conclusions
(Supplementary Section 18 and Supplementary Fig. 20). The
observed patterns thus suggest the need for a detailed follow-up in
a dedicated future study involving a larger cohort of families who
explicitly do not take thiamine supplements. Furthermore, in light
of the T1DM-related ﬁndings (Fig. 6), the levels of pancreatic and
immune-related proteins should be measured alongside functional
microbial proﬁles in longitudinal pre-diabetes studies to establish
the timing of their decrease and elucidate whether they play a role in
the changes in the microbiota associated with diabetes development.
Discussion
By dissecting the gastrointestinal microbial community structures
resolved using the individual omic data sets, we have shown that
community structures are reﬂected across all omic levels.
Nonetheless, the apparent higher complexity and variability exhib-
ited by the functional omic levels necessitates an integrated analysis
of the individual omic data sets18,50 to facilitate a reliable link
between speciﬁc microbial genes and their genomic context.
Linking genes of interest to genomic context has been attempted
in other studies of T1DM by correlating abundances of functional
traits and organisms32. However, as demonstrated, transcript levels
cannot be expected to simply depend on the abundances inferred
from metagenomic data. We therefore developed the presented
framework for genome reconstructions, which served as the basis
for the subsequent integration of the multi-omic data.
All omic levels exhibited individuality and family speciﬁcity,
which has previously been described only for metagenomes3–5. The
observed individual patterns in relation to secreted human proteins
may well be an important factor shaping the gastrointestinal micro-
biome, culminating in the observed individuality. With regard to
T1DM, differences in the relative abundances of certain human pan-
creatic enzymes in the stool were observed, and the abundances of
these proteins correlated with the expression of microbial genes
involved in metabolic transformations with possible relevance to
T1DM, including thiamine synthesis and glycolysis. Finally, our
results clearly indicate that several microbial populations can con-
tribute to functional differences between samples, underpinning
the importance of integrated multi-omic analyses. The methods
and data presented in this case study will serve to inform the
design of future large-scale studies, which should, in addition to
multi-omic data, involve the collection of high-quality clinical and
nutritional data, to allow the establishment of host–microbe pheno-
typic associations in the context of human health and disease.
Methods
Ethics. Written informed consent was obtained from all subjects enrolled in the
study. This study was approved by the Comité d’Ethique de Recherche (CNER;
reference no. 201110/05) and the National Commission for Data Protection
in Luxembourg.
Anthropometric, nutritional, clinical data and blood and stool sampling. The
study design was an observational study of four purposely selected family groups
containing at least two members with T1DM and healthy individuals in two
generations or more, from existing patient cohorts from the Centre Hospitalier du
Luxembourg. Recruited families were seen three times at intervals of between four
and eight weeks to have data and samples collected (Supplementary Table 1). On
enrolment, study participant pedigrees were drawn, medical history was collected
and a ‘Food Frequency Questionnaire’ was completed (estimating the foods eaten
over the last 12 months). During every visit, anthropometric data were recorded. All
participants were weighed and measured using the SECA combined scale and
measuring device. Body mass index was calculated as kg m−2. Blood pressure was
taken in the sitting position with a SureSigns VM6.
Daily recall questionnaires for food intake in the 24 h preceding the visit were
ﬁlled in on visits 2 and 3. Nutritional content of the reported food was estimated
based on the food frequency or daily recall questionnaires using FETA software51.
Faecal samples were self-collected at three time points (if bowel movement
permitted sampling) and immediately placed on dry ice and subsequently
transported and stored without thawing. Blood was collected using standard
venepuncture and processed using validated processes52. Samples and associated
data used in this study were processed and stored at IBBL (Integrated BioBank of
Luxembourg) following ISO17025:2005 standards and the International Society for
Biological and Environmental Repositories (ISBER) best practices.
Blood analytics. Islet cell antibodies were measured using the test from INOVA
Diagnostics. Insulin antibodies, tyrosine phosphatase-related islet antigen 2
antibodies, glutamate decarboxylase 2 antibodies and zinc-transporter 8 antibodies
were measured using enzyme-linked immunosorbent assay (ELISA) kits from RSR.
Measurements of glucose, glutamate-oxalacetate-transaminase, glutamate-pyruvate-
transaminase, γ-glutamyltransferase, cholesterol, low-density cholesterol, high-
density cholesterol and triglycerides were performed on a Cobas c501 analyser
(Roche) with appropriate reagents (Roche). Quantiﬁcation of glycated haemoglobin
was performed on an Integra 400 analyser (Roche) with a kit from the same
company. Insulin and the C-peptide were measured on a Cobas e601 (Roche) with
matching kits (Roche). Leptin and pro-insulin were quantiﬁed using ELISA kits
(Beckman Coulter). Thiamine levels in plasma were measured in technical
duplicates using a vitamin B1 ELISA kit (Cloud-Clone) according to the
manufacturer’s protocol.
Extraction of biomolecular fractions from faecal samples. Biomolecular fractions
were extracted from unthawed, frozen faecal subsamples (150 mg) after pretreatment
of the weighed subsamples with 1.5 ml RNAlater ICE (LifeTechnologies) overnight.
The faeces-RNAlater ICE mixture was homogenized by bead-beating, as previously
described53. Differential centrifugation and extraction using the All-In-One kit
(Norgen Biotek) to recover DNA and proteins were carried out as previously
described53. DNA fractions were supplemented with DNA extracted from 200 mg
subsamples using the MOBIO Power Soil Kit.
RNAwas extracted from faecal subsamples (250 mg), which were pretreated with
RNAlater ICE (LifeTechnologies) as described above. Homogenization and differential
centrifugation were carried out as described previously53 and the pellet was lysed with
MOBIO glass bead tubes. RNAwas extracted using the MOBIO PowerMicrobiome
RNA Isolation Kit, according to themanufacturer’s recommendations. The integrity of
isolated RNA fractions was assessed using an Agilent Bioanalyzer2000. Only fractions
with an RNA integrity number > 7 were subjected to sequencing.
Metagenomic DNA and RNA sequencing. DNA was sequenced with 101 bp
(per paired end) on a HiSeq2000 system (Illumina) by BGI. Libraries with an insert
size of 350 bp were constructed from metagenomic DNA by fragmentation by
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sonication (Covaris), end-repair, adenylation, adapter ligation and ampliﬁcation of
adapter-ligated DNA fragments using appropriate enzymes (Enzymatics). Library
ampliﬁcation and cluster generation were performed using a TruSeq PE Cluster Kit
V3–cBot–HS (Illumina) and ﬂow cells were sequenced to 101 bp per paired end.
Strand-speciﬁc cDNA libraries were constructed from rRNA-depleted RNA
fractions and sequenced to 150 bp (per paired end) on an Illumina HiSeq2500 by
Oxford Gene Technologies. In detail, rRNA was depleted from the RNA fractions
using Epibio’s Universal Bacteria Ribozero Kit. Stranded cDNA libraries were
constructed using the NEBNext Ultra Directional RNA Library Prep Kit. Libraries
were sequenced to 150 bp (paired-end) using TruSeq Rapid SBS Kits v1 (Illumina).
Filtering and trimming of metagenomic and metatranscriptomic reads. The
in silico analysis results presented in this Article were obtained using the high-
performance computing facilities of the University of Luxembourg54. Metagenomic
and metatranscriptomic paired-end reads in fastq format for each individual and
each time point were processed separately using the MOCAT pipeline55. First,
reads were trimmed using the MOCAT trimming and quality ﬁltering step (MOCAT.
pl –rtf ) with the following parameter settings: readtrimﬁlter_length_cutoff=40,
readdtrimﬁlter_qual_cutoff=20, readtrimﬁlter_use_sanger_scale=yes,
readtrimﬁlter_trim_5_prime=yes and readtrimﬁlter_use_precalc_5prime_
trimming=no. This step generated paired- and single-end reads, which were
then mapped to the human genome (hg19) using the MOCAT screening step
(MOCAT.pl –s hg19), which used SOAPaligner v2.21 (ref. 56) and then ﬁltered
mapping reads out. Metatranscriptomic reads were then also screened against
the human RNA transcripts as deﬁned for hg19 by Ensembl (release 66) to
additionally remove reads overlapping splice sites in human transcripts. MOCAT
screening was run with the following parameter setting: screen_length_cutoff=30,
screen_percent_cutoff=90, screen_soap_seed_length=30, screen_soap_max_mm=10,
screen_soap_cmd=-M 4 and screen_save_format=sam. This step resulted in two sets
of reads in fastq format (human and non-human), each consisting of paired- and
single-end reads. To assess the rRNA content of the sequencing libraries,
metatranscriptomic reads were independently mapped against the prokaryotic
and eukaryotic parts of the SILVA database57 using Bowtie2 (ref. 58). The
non-human ﬁles were used for taxonomic analyses as well as assembly
(Supplementary Figs 21 and 22).
Read-based taxonomic analyses, mOTU analyses and use of an integrated gene
catalogue. mOTU analysis for taxonomic proﬁling was separately performed for
trimmed and ﬁltered metagenomic and metatranscriptomic reads for each sample
using the MOCAT pipeline38,55 and the mOTU.v1.padded reference database
(Supplementary Fig. 21), which comprises genes for the ribosome-binding ATPase
(YchF; GTP1/OBG family), phenylalanyl-tRNA-synthetase alpha subunit, arginyl-
tRNA-, seryl-tRNA-, cysteinyl-tRNA-, leucyl-tRNA- and valyl-tRNA-synthetase,
tRNA A37 threonylcarbamoyltransferase (TsaD), and two signal recognition particle
GTPases (COG0012, COG0016, COG0018, COG0172, COG0215, COG0495,
COG0525, COG0533, COG0541 and COG0552, respectively)38. Metagenomic and
metatranscriptomic codes to recognize donors were built from mOTU relative
abundances and evaluated using Idability39 with the –meta_mode setting.
Taxonomic proﬁling of reads and contigs was also performed using Kraken59
with a database comprising 9,464 prokaryotic and 2,326 viral genomes.
Metagenomic reads were mapped against the integrated gene catalogue (IGC)60 and
genus-level abundance proﬁles were calculated as described in the publication of the
integrated gene catalogue60. These proﬁles were concatenated with the proﬁles of
1,267 samples distributed with the IGC. A Jensen–Shannon divergence matrix was
calculated using the phyloseq61 implementation over all proﬁles, and partitioning
around medoids62 was performed to obtain enterotype annotations for each sample.
Co-assembly of metagenomic and metatranscriptomic reads. Trimmed and
ﬁltered metagenomic and metatranscriptomic reads were merged and made
non-redundant using cd-hit-dup from the CD-HIT software suite63. The non-
redundant set of non-human paired-end reads was then assembled using a
combined metagenomic and metatranscriptomic assembly pipeline
(Supplementary Fig. 22).
Reads were ﬁrst converted from fastq to fasta format using the fq2fa script
( fq2fa -merge -ﬁlter) provided by IDBA-UD (ref. 64). IDBA-UD was then run using
its pre-error-correction step for correcting reads (idba_ud –pre_correction). In the
next step, the contigs assembled by IDBA-UD were extended using the unused
paired- and single-end reads and the Velvet assembly tool65 (version 1.2.07). For
this, the paired-end reads were mapped onto the previously assembled contigs using
SOAPaligner v2.21 (ref. 56; with parameter -r 2 -M 4 -l 30 -v 10 -p 8 -u unmapped.fa).
The unused single-end reads were combined with the unmapped reads and
cd-hit-dup from the CD-HIT software suite63 was used to remove duplicate reads.
Velvet was then run over a range of k-mer sizes (27, 31, 35, 39, 43, 47, 51, 55, 59, 63)
with the IDBA-UD contigs as long read input (velveth parameters: -long contig.fa,
velvetg parameter: -conserveLong yes). Afterwards, all newly assembled contig sequences
from the different k-mer runs and the original IDBA-UD contigs were concatenated
and clustered using cd-hit from the CD-HIT software suite (parameter: -c 0.99) to
remove redundancy. Newbler from MeGAMerge 1.1 (ref. 66) was then used to join
and extend the clustered contigs. Minimal contig length was set to 125 bps.
Gene predictions, functional and phylogenetic annotation. Prodigal v2.60
(ref. 67) (parameter: -p meta) was used for gene prediction on the ﬁnal set of contigs.
Essential single-copy genes68 among the protein predictions were detected as
described69. Marker genes for phylogenetic analysis were predicted using Amphora2
(ref. 70) and fetchMG (ref. 38). rRNA genes were predicted using Barrnap (http://
www.vicbioinformatics.com/software.barrnap.shtml). Functional gene annotations
were generated using HMMER 3.1 (refs 71,72) against multiple pre-compiled and
in-house annotation databases. Existing databases for PFAM (ref. 73) and
TIGRFAM (ref. 74) were downloaded from their web pages. Additionally, hidden
Markov models (HMMs) were trained for all KEGG orthologous groups (KOs) after
aligning the protein sequences using T-Coffee (ref. 75). Enzyme-speciﬁc HMMs
were generated for MetaCYC (ref. 76) and UNIPROT (ref. 77) using only enzyme
annotations with at least three digit Enzyme Commission (EC) numbers, as
described previously78. The best hit in each HMM set was associated to each gene, if
the HMM score was higher than the binary logarithm of the number of target genes
(19.6 ± 0.2), in accordance with the recommendations in the HMMer manual.
Determination of metagenomic and metatranscriptomic depths of coverage of
contigs and ORFs.Metagenomic and metatranscriptomic paired-end and singleton
reads of each sample were mapped against contigs using Bowtie2 (ref. 58) and
default settings. Average depths of coverage were calculated using SAMtools (ref. 79)
and a custom perl script. Quality-trimmed metagenomic paired-end and singleton
reads were mapped against predicted protein- or RNA-coding regions using Bowtie2
with default settings and in addition to depth of coverage, the numbers of mapping
reads were counted. Stranded metatranscriptomic paired-end and singleton reads
were mapped against predicted protein- or RNA-coding regions using Bowtie2 with
–fr –nofw settings to obtain coverage depth and read counts for reads mapping in the
sense direction.
To obtain whole-community metagenomic or metatranscriptomic functional
proﬁles, sums of all read counts for functionally annotated genes were calculated for
every functional category. If two functions were assigned to the same gene with the
same likelihood, the number of reads for this gene was divided equally between
both functions.
Binning of contigs from metagenomic and metatranscriptomic co-assembly.
Two-dimensional maps for every contig ≥1 kbp were generated for each sample as
described previously80. In short, for every contig ≥1 kbp, pentanucleotide
frequencies were computed, which represent the genomic fragments as points in a
512-dimensional space (frequencies of individual pentamers and their reverse
complements were summed). This matrix was subsequently transformed by log ratio
and centred. Following this, the high-dimensional data were embedded into a
two-dimensional space using Barnes–Hut stochastic neighbour embedding and the
resulting two-dimensional maps were used for clustering. As rRNA-coding regions
have been shown to challenge clustering based on genomic signature80, 16S/18S and
23S/28S sequences were removed from the contigs prior to the calculation of
pentamer frequencies as long as a minimum length of 1 kbp was retained.
Two-dimensional maps of contigs were visualized in R. Clusters were binned using
an automatic workﬂow based on DBSCAN (ref. 81) (Supplementary Fig. 23). Brieﬂy,
two-dimensional coordinates were clustered using the dbscan function in the R
package fpc. In the ﬁrst pass, the parameters were ten minimum neighbourhood
points and the Eps value was estimated based on the recommendations of the
authors of DBSCAN. Number and multiplicity of essential genes68,69 were used to
judge completeness of clusters. Clusters with multiple copies of the same essential
genes were divided further by analysing the metagenomic coverage depth of the
essential genes using the Hartigans’ diptest as implemented in the R package diptest.
If unimodality was rejected, a normal mixture model (implemented in the R package
mixtools, ref. 82) was used to ﬁnd a cutoff to bin the contigs by metagenomic depth
of coverage. These two steps were repeated three times on all overcomplete bins, and
the number of minimum neighbourhood points was raised by 2 in each step.
Binned population-level genomic complements were linked to mOTUs used in
the taxonomic analysis by calling the marker genes using fetchMG (ref. 38) on the
predicted ORFs, aligning the predicted marker genes against the database used for
mOTU analysis and assigning to each called marker gene the taxonomy of the
closest hit.
Human DNA sequencing and analysis. Genomic DNA was isolated from buffy
coats of human blood samples using validated processes according to the
requirements of Complete Genomics (CG). Whole-genome sequencing (WGS) was
performed by CG using their proprietary paired-end nanoarray-based sequencing-
by-ligation technology83. All sequencing data quality control, mapping and variant
calling were carried out by CG as part of their sequencing service using the Standard
Sequencing Service pipeline version 2.4. Sequencing reads were mapped against the
NCBI build 37. For gene annotations, NCBI build 37.2 (RefSeq) was used. For details
on coverage and called variants see Supplementary Table 3. All subsequent analyses
were performed using the family WGS analysis pipeline as previously described84. In
short, as input for the WGS analysis pipeline, we ﬁrst combined all the variants from
all genomes of one family into the union of variants using the CGAtools (CG
Analysis Tools) listvariant command and CG var-ﬁles as input. We used CGAtools
version 1.6 as provided by CG (available from http://cgatools.sourceforge.net). Next,
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we used the CGAtools testvariant command to test each genome for the presence of
each variant. Only variants that were called in at least one genome of a family as
high-quality calls (VQHIGH) by CG were used for further analysis.
Database generation for metaproteomic analyses. Sample-speciﬁc search
databases were constructed from individual-speciﬁc pseudo-phased human proteins
including homo- and heterozygous variants, as well as microbial proteins predicted
based on the combined metagenomic and metatranscriptomic assemblies after
inclusion of all called variants (Supplementary Fig. 24). In detail, for each human
genome, small variants (single nucleotide polymorphisms and small insertions,
deletions and substitutions shorter than 200 bp) were annotated using ANNOVAR
(ref. 85) (version 2015Mar12) using the NCBI RefSeq release 60 and the Ensembl
release 74 genome annotations. An individualized personal reference genome for
each sample was generated by incorporating short homozygous variants into the
hg19 reference genome. For each RefSeq protein-coding isoform, the new coding
(CDS) mRNA sequence was extracted from the personalized reference genome
and then translated. To also include heterozygous exonic amino acid changing
variants, only exonic variants that were annotated as non-synonymous, stop gain,
stop loss, (non-)frameshift insertions, deletions or substitutions were kept.
Because no phasing information for the heterozygous variants was available, we
generated pseudo-phased proteins by adding one copy per protein including all
homo- and heterozygous variants. For each individual genome, a FASTA protein
sequence database was then created by combining two FASTA databases: (1)
REFSEQ protein sequences from the personalized human genome reference hg19
and (2) protein sequences containing heterozygous variants (proteins were marked
if they contained homo- or heterozygous amino acid changes, respectively, or no
change at all). Proteins with newly introduced stop codons were cut after the
stop codon.
For the metaproteomic databases, variants were called per faecal sample on all
predicted ORFs from the alignment results of mapping metagenomic and
metatranscriptomic reads against the contigs using Platypus variant caller86 and
vcftools (ref. 87). Variants with low mapping quality (MQ ﬂag) were discarded.
Multiple variants called on the same ORF were combined to yield the minimal
number of variant proteins without contradictory overlap of variants using a custom
perl script. The variant proteins as well as the consensus protein from the assembly
were kept. Incomplete predicted proteins (or variant proteins) were removed, if no
full tryptic peptide was expected from the prediction.
Protein liquid chromatography (LC) and mass spectrometry. An aliquot of 15 µg
isolated protein fraction was reduced (dithiothreitol) and alkylated (iodoacetamide)
and the proteins precipitated using the Clean-up Kit (GE Healthcare) according to
the manufacturer’s instructions. The protein pellets were resuspended at a
concentration of 500 µg ml–1 in 50 mM ammonium bicarbonate to perform a
complete trypsin digestion. Digested protein (3.5 µg) was puriﬁed on a Ziptip C18
(Millipore), dried and resuspended in 100 mM ammonium formiate (pH 10) at
333 ng µl–1. Digested protein (3 µg) was injected on a Nano 2D UPLC – Orbitrap
MS system (2D-nanoAcquity UPLC (Waters) and Q-Exactive (Thermo)). MPDSMIX
(Waters) was spiked in at 150 fmol of ADH (yeast alcohol dehydrogenase) digest per
injection. Measurements were performed on technical triplicates.
A 2D LC method with three steps of 180 min was run. The three steps were run
on a column at high pH with increasing percentages of acetonitrile, and the eluted
peptides were diluted and loaded on a low pH column, where each step consisted of a
gradient of 5 min from 99% of A (A = 0.1% formic acid in water; B = acetonitrile) to
93% of A followed by a gradient of 135 min from 93% of A to 65% of A.
Mass spectrometry was performed using a TopN-MSMS method (N = 12), with
parameters as follows: mass range from 400 to 1,750 m/z, resolution 70,000, AGC
target 106 or maximum injection time 200 ms. MS2 parameters for spectrum
acquisition were an isolation window of 1.6 m/z, normalized collision energy (NCE)
of 25, resolution of 17,500, AGC target of 105 or maximum injection time of 50 ms.
The database searches were performed using Proteome Discoverer (v 1.4,
Thermo Scientiﬁc) and Sequest HT on the protein predictions. Proteomics
measurements and database searches were carried out by the proteomics facility of
the Center of Analytical Research and Technology – Groupe Interdisciplinaire de
Génoprotéomique Appliquée (CART-GIGA, Liège, Belgium). Peptide spectrum
matches with at least a high conﬁdence and a delta Cn better than 0.05 were
considered, with fragment mass tolerance of 0.02 Da and precursor mass tolerance
of 5 ppm. Peptides of 6–144 amino acids with a maximum of two missed cleavage
sites were considered. Peptides were grouped by mass and sequences and validated
based on q-values with FDR < 0.01. A minimal number of one unique peptide was
required for protein identiﬁcation. The strict maximum parsimony principle was
applied and the grouping of proteins that could not be differentiated into protein
groups based on their peptide masses was enabled. Areas under the ion-
chromatography curves for proteins were quantiﬁed based on the top three unique
peptides. Relative protein abundances of human proteins were calculated by addition
of the areas under the curve of all protein groups containing one or more variant of
one or more isoform of a single gene product. Similarly, the sum was calculated of
the areas under the curve of all protein groups containing only genes and/or variants
of genes annotated with the same function.
Integrated data handling and comparative, ecological and network analyses. All
functional and taxonomic annotations, read coverage data, positions and frequencies
of variants and relative protein abundances for the contigs and their associated ORFs
were stored in a MongoDB (v. 3.0.3) collection (Supplementary Fig. 25). Retrieval of
data for further analyses in R (ref. 88) was accomplished using the
package rmongodb.
Bray–Curtis dissimilarity indices were calculated, and permutational MANOVA
(multivariate analysis of variance; aka ‘adonis’89) was performed using the R package
vegan on sum-normalized relative abundances. Unseen90 mOTUs were estimated
using ‘estimateR’ from vegan. Total Soerensen dissimilarity indices were calculated
using the R package betapart (ref. 91) on sum-normalized relative abundances.
Jensen–Shannon divergences were calculated using the implementation in the R
package phyloseq (ref. 61), also on sum-normalized relative abundances. Principal
coordinate analyses were carried out using the R package ape 3.2 (ref. 92). Multiple
co-inertia analysis was performed using the R package omicade4 (ref. 93) using
scaled data (in accordance with the manual’s recommendations).
Median numbers per individual of metagenomic or metatranscriptomic reads
mapping to the protein-coding mOTU (ref. 38) marker genes and of metagenomic
and metatranscriptomic reads mapping to functionally annotated genes were used
for differential analyses by applying the R package DESeq2 (ref. 94) (see
Supplementary Table 1 for numbers of samples per individual). To ﬁnd differences
between the individuals with T1DM and healthy individuals, the main effect of
T1DM in a model accounting for family membership and T1DM was analysed. For
differences between relative protein abundances, Wilcoxon rank sum tests or
Kruskal–Wallis tests were applied.
Network analysis was performed on a gene-centric generalized network of KOs,
built as described in ref. 37 by using shared products/educts of reactions related to
KOs detected at the metatranscriptomic level, to link these KOs using a custom R
script and functions from R packages graph, igraph (ref. 95) and BioNet (ref. 96).
Top-scoring modules were extracted using BioNet and Heinz (ref. 97), using
P values of differential or correlation analyses (without multiple testing adjustment).
Metatranscriptomic abundances, fold changes or correlations within KEGG
pathways were visualized using the R package pathview (ref. 98).
Data and code availability.Metagenomic and metatranscriptomic sequencing reads
can be accessed from NCBI BioProject PRJNA289586. Assembled contigs and gene
predictions can be accessed at MG-RAST (ref. 99) (submission IDs are shown in
Supplementary Table 7). The mass spectrometry proteomics data have been
deposited at the ProteomeXchange Consortium (http://proteomecentral.
proteomexchange.org) via the PRIDE partner repository100 with the data set
identiﬁer PXD003791. The 200 binned population-level genomes with >93%
completeness can be accessed via the guest account at RAST (ref. 101) (submission
IDs are shown in Supplementary Table 4). Custom scripts are available at
https://git-r3lab.uni.lu/anna.buschart/MuStMultiomics.
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